Role of serotonin in memory impairment

Annals of Medicine

Volumn 32, Issue 3, 2000, Pages 210-221

  Buhot, Marie Christine ^a   Martin, Stéphanie ^a   Segu, Louis ^a  

^a CNRS   (France)

Author keywords

Alzheimer's disease; Behaviour; Knock out mice; Learning and memory; Mice; Pharmacology; Rat; Serotonin; Serotonin receptors

Indexed keywords

RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ALZHEIMER DISEASE; AMNESIA; CHOLINERGIC SYSTEM; DOPAMINERGIC SYSTEM; FRONTAL CORTEX; GABAERGIC SYSTEM; HIPPOCAMPUS; HUMAN; LEARNING; MEMORY; OLIVARY NUCLEUS; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM;

EID: 0034100397     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853890008998828     Document Type: Review

References (125)

1. Buhot M-C. Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 1997; 7: 243-54.
2. Sirviö J, Riekkinen P Jr, Jäkälä P, Riekkinen PJ. Experimental studies on the role of serotonin in cognition. Prog Neurobiol 1994; 43: 363-79.
3. Soubrié P. Reconciling the role of central serotonin neurons in human and animal behaviour. Behav Brain Sci 1986; 9: 319-64.
4. Wogar MA, Bradshaw CM, Szabadi E. Effect of lesions of the ascending 5-hydroxytryptaminergic pathways on choice between delayed reinforcers. Psychopharmacology 1993; 111: 239-43.
5. Asin KE, Wirtshafter D, Kent EW. Impaired patterned responding in rats with electrolytic median raphe lesions. Physiol Behav 1979; 23: 803-6.
6. Beninger RJ, Phillips AG. Possible involvement of serotonin in extinction. Pharmacol Biochem Behav 1979; 10: 37-41.
7. Gonzalez-Burgos I, Perez-Vega MI, Del Angel-Meza AR, Feria-Velasco A. Effect of tryptophan restriction on short-term memory. Physiol Behav 1998; 63: 165-9.
8. Riedel WJ, Klaassen T, Deutz NE, van Someren A, van Praag HM. Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology 1999; 141: 362-9.
9. Stancampiano R, Cocco S, Melis F, Cugusi C, Sarais L, Fadda F. The decrease of serotonin release induced by tryptophan-free amino acid diet does not affect spatial and passive avoidance learning. Brain Res 1997; 762: 269-74.
10. Mazer C, Muneyyirci J, Taheny K, Raio N, Borella A, Whitaker-Azmitia P. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res 1997; 760: 68-73.
11. Brezun JM, Daszuta A. Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience 1999; 89: 999-1002.
12. Altman HJ, Normile HJ, Galloway MP, Ramirez A, Azmitia EC. Enhanced spatial discrimination learning in rats following 5,7-DHT-induced serotonergic deafferentation of the hippocampus. Brain Res 1990; 18: 61-6.
13. Ward BO, Wilkinson LS, Robbins TW, Everitt BJ. Forebrain serotonin depletion facilitates acquisition and performance of a conditional visual discrimination task in rats. Behav Brain Res 1999; 100: 51-65.
14. Al-Zahrani SSA, Ho M-Y, Velazquez-Martinez DN, Lopez Cabrera M, Bradshaw CM, Szabadi E. Effect of destruction of the 5-hydroxytryptaminergic pathways on the acquisition of temporal discrimination and memory for duration in a delayed conditional discrimination task. Psychopharmacology 1996; 123: 103-10.
15. Lister S, Pearce JM, Butcher SP, Collard KJ, Foster GA. Acquisition of conditioned inhibition in rats is impaired by ablation of serotoninergic pathways. Eur J Neurosci 1996; 8: 415-23.
16. Avanzi V, Castilho VM, de Andrade TG, Brandao ML. Regulation of contextual conditioning by median raphe nucleus. Brain Res 1998; 790: 178-84.
17. Santucci AC, Knott PJ, Haroutunian V. Excessive serotonin release, not depletion, leads to memory impairments in rats. Eur J Pharmacol 1996; 295: 7-17.
18. Nelson CJ, Jordan WP, Bohan RT. Daily fluoxetine administration impairs avoidance learning in the rat without altering sensory thresholds. Prog Neuro-Psychopharmacol Biol Psychiat 1997; 21: 1043-57.
19. Richter-Levin G, Segal M. Serotonin, aging and cognitive functions of the hippocampus. Rev Neurosci 1996; 7: 103-13.
20. Morgan MJ. Memory deficits associated with recreational use of 'ectasy' (MDMA). Psychopharmacology 1999; 141: 30-6.
21. Inoue T, Tsuchiya K, Koyama T. Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmacol Biochem Behav 1994; 49: 911-20.
22. Inoue T, Tsuchiya K, Koyama T. Serotonin activation reduces defensive freezing in the conditioned fear paradigm. Pharmacol Biochem Behav 1996; 53: 825-31.
23. Wilkinson LS, Humby T, Robbins TW, Everitt BJ. Differential effects of forebrain 5-hydroxytryptamine depletions on Pavlovian aversive conditioning to discrete and contextual stimuli in the rat. Eur J Neurosci 1995; 7: 2042-52.
24. Graeff FG, Viana MB, Mora PO. Opposed regulation by dorsal raphe nucleus 5-HT pathways of two types of fear in the elevated T-maze. Pharmacol Biochem Behav 1996; 53: 171-7.
25. Handa RJ, George M, Gordon BH, Campbell DB, Lorens SA. Responses to novelty stress in female F344 rats: effects of age and d-fenfluramine. Pharmacol Biochem Behav 1996; 53: 641-7.
26. Harrison AA, Everitt BJ, Robbins TW. Central serotonin depletion facilitates the acquisition and performance of a conditional visual discrimination task in rats. Behav Brain Res 1999; 100: 99-112.
27. Sirviö J. Strategies that support declining cholinergic neurotransmission in Alzheimer's disease patients. Gerontology 1999; 45 Suppl 1: 3-14.
28. Richter-Levin G, Segal M. Age-related cognitive deficits in rats are associated with a combined loss of cholinergic and serotonergic functions. Ann N Y Acad Sci 1993; 695: 254-7.
29. Decker MW, McGaugh JL. The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 1991; 7: 151-68.
30. Cassel J-C, Jeltsch H. Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience 1995; 69: 1-41.
31. Steckler T, Sahgal A. The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav Brain Res 1995; 67: 165-99.
32. Ruotsalainen S, Miettinen R, MacDonald E, Riekkinen M, Sirviö J. The role of the dorsal raphe-serotonergic system and cholinergic receptors in the modulation of working memory. Neurosci Biobehav Rev 1998; 22: 21-31.
33. Markowska AL, Wenk GL. Serotonin influences the behavioral recovery of rats following nucleus basalis lesions. Pharmacol Biochem Behav 1991; 38: 731-7.
34. Kocsis B, Vertes RP. Midbrain raphe cell firing and hippocampal theta rhythm in urethane anaesthetized rats. Neuroreport 1996; 7: 2867-72.
35. McQuade R, Sharp T. Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J Neurochem 1997; 69: 791-6.
36. Matsukawa M, Ogawa M, Nakadate K, Maeshima T, Ichitani Y, Kawai N, et al. Serotonin and acetylcholine are crucial to maintain hippocampal synapses and memory acquisition in rats. Neurosci Lett 1997; 230: 13-6.
37. Stancampiano R, Cocco S, Cugusi C, Sarais L, Fadda F. Serotonin and acetylcholine release response in the rat hippocampus during a spatial memory task. Neuroscience 1999; 89: 1135-43.
38. Beiko J, Candusso L, Cain DP. The effect of nonspatial water maze pretraining in rats subjected to serotonin depletion and muscarinic receptor antagonism: a detailed behavioural assessment of spatial performance. Behav Brain Res 1997; 88: 201-11.
39. Harder JA, Kelly ME, Cheng CH, Costall B. Combined pCPA and muscarinic antagonist treatment produces a deficit in rat water maze acquisition. Pharmacol Biochem Behav 1996; 55: 61-5.
40. Harder JA, Kelly ME. The effect of several putative cognition enhancers on a water maze acquisition deficit induced by pCPA + scopolamine combination treatment. Pharmacol Biochem Behav 1997; 56: 657-61.
41. Balse E, Lazarus C, Kelche C, Jeltsch H, Jackisch R, Cassel J-C. Intrahippocampal grafts containing cholinergic and serotonergic fetal neurons ameliorate spatial reference but not working memory in rats with fimbria-fornix/cingular bundle lesions. Brain Res Bull 1999; 49: 263-72.
42. Milner TA, Veznedaroglu E. Serotonin-containing terminals synapse on septohippocampal neurons in the rat. J Neurosci Res 1993; 36: 260-71.
43. Farr SA, Uezu K, Flood JF, Morley JE. Septo-hippocampal drug interactions in post-trial memory processing. Brain Res 1999; 847: 221-30.
44. Hoyer D, Martin GR. Classification and nomenclature of 5-HT receptors: a comment on current issues. Behav Brain Res 1996; 73: 263-8.
45. Gobert A, Rivet JM, Cistarelli L, Millan MJ. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935. J Neurochem 1997; 68: 1159-63.
46. Hajós-Korcsok E, Sharp T. 8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors. Eur J Pharmacol 1996; 314: 285-91.
47. Herremans AHJ, Hijzen TH, Olivier B, Slangen JL. Serotonergic drug effects on a delayed conditional discrimination task in the rat: involvement of the 5-HT1A receptor in working memory. J Psychopharmacol 1995; 9: 242-50.
48. Warburton EC, Harrison AA, Robbins TW, Everitt BJ. Contrasting effects of systemic and intracerebral infusions of the 5-HT1A receptor agonist 8-OH-DPAT on spatial short-term working memory in rats. Behav Brain Res 1997; 84: 247-58.
49. Ohno M, Watanabe S. Blockade of 5-HT1A receptors compensates loss of hippocampal cholinergic neurotransmission involved in working memory of rats. Brain Res 1996 736: 180-8.
50. Ohno M, Kishi A, Watanabe S. Effect of cholinergic activation by physostigmine on working memory failure caused in rats by pharmacological manipulation of hippocampal glutamatergic and 5-HTergic neurotransmission. Neurosci Lett 1996; 217: 21-4.
51. Kant GJ, Meininger GR, Maughan KR, Wright WL, Robinson TN III, Neely TM. Effects of the serotonin receptor agonists 8-OH-DPAT and TFMPP on learning as assessed using a novel water maze. Pharmacol Biochem Behav 1996; 53: 385-90.
52. Riekkinen M, Sirviö J, Toivanen T, Riekkinen P Jr. Combined treatment with a 5-HT1A receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior. Psychopharmacology 1995; 122:137-46.
53. Carli M, Luschi R, Garofalo P, Samanin R. 8-OH-DPAT impairs spatial but not visual learning in a water maze by stimulating 5-HT1A receptors in the hippocampus. Behav Brain Res 1995; 67: 67-74.
54. Carli M, Bonalumi P, Samanin R. Stimulation of 5-HT1A receptors in the dorsal raphe reverses the impairment of spatial learning caused by intrahippocampal scopolamine in rats. Eur J Pharmacol 1998; 10: 221-30.
55. Carli M, Balducci C, Millan MJ, Bonalumi P, Samanin R. S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Br J Pharmacol 1999; 128: 1207-14.
56. Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, et al. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res 1996; 73: 337-53.
57. Carli M, Luschi R, Samanin R. (S)-WAY 100135, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Eur J Pharmacol 1995; 283: 133-9.
58. Carli M, Bonalumi P, Samanin R. WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid. Brain Res 1997; 774: 167-74.
59. Carli M, Silva S, Balducci C, Samanin R. Way 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by blockade of hippocampal NMDA receptors. Neuropharmacology 1999; 38: 1165-73.
60. Harder JA, Maclean CJ, Alder JT, Francis PT, Ridley RM. The 5-HT1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset. Psychopharmacology 1996; 127: 245-54.
61. Guimares FS, Del Bel EA, Padovan CM, Netto SM, de Almeida RT. Hippocampal 5-HT receptors and consolidation of stressful memories. Behav Brain Res 1993; 58: 133-9.
62. Liang KC, Tsui KY, Tyan YM, Chiang TC. Buspirone impaired acquisition and retention in avoidance tasks: involvement of the hippocampus. Chin J Physiol 1998; 41: 33-44.
63. Maier SF, Grahn RE, Watkins LR. 8-OH-DPAT micro-injected in the region of the dorsal raphe nucleus blocks and reverses the enhancement of fear-conditioning and interference with escape produced by exposure to inescapable shock. Behav Neurosci 1995 109: 404-12.
64. Balleine BW, Fletcher N, Dickinson A. Effect of the 5-HT1A agonist, 8-OH-DPAT on instrumental performance in rats. Psychopharmacology 1996; 125: 79-88.
65. Ramboz S, Oosting R, Ait Amara D, Kung HF, Blier P, Mendelsohn M, et al. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci U S A 1998; 95: 14476-81.
66. Parks CL, Robinson PS, Sibille E, Shenk T, Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci U S A 1998; 95: 10734-9.
67. Heisler LK, Chu H-M, Brennan TJ, Danao JA, Bajwa P, Parsons LH, et al. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci U S A 1998; 95: 15049-54.
68. Kinney GG, Kocsis B, Vertes RP. Medial septal unit firing characteristics following injections of 8-OH-DPAT into the median raphe nucleus. Brain Res 1996; 708: 116-22.
69. Kia HK, Brisorgueil MJ, Daval G, Langlois X, Hamon M, Vergé D. Serotonin1A receptors are expressed by a subpopulation of cholinergic neurons in the rat medial septum and diagonal band of Broca. A double immunocytochemical study. Neuroscience 1996; 74: 143-54.
70. Schmitz D, Empson RM, Heinemann U. Serotonin reduces inhibition via 5-HT1A receptors in area CA1 of rat hippocampal slices in vitro. J Neurosci 1995 15: 7217-25.
71. Koyama T, Nakajima Y, Fujii T, Kawashima K. Enhancement of cortical and hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by BAY x 3702 in freely moving rats. Neurosci Lett 1999; 265: 33-6.
72. Nakai K, Fujii T, Fujimoto K, Suzuki T, Kawashima K. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis. Neurosci Res 1998; 31: 23-9.
73. Buhot M-C, Patra SK, Naïli S. Spatial memory deficits following stimulation of hippocampal 5-HT1B receptors in the rat. Eur J Pharmacol 1995; 285: 221-8.
74. Sari Y, Lefèvre K, Bancila M, Quignon M, Miquel MC, Langlois X, et al. Light and electron microscopic immunocytochemical visualization of 5-HT1B receptors in the rat brain. Brain Res 1997; 760: 281-86.
75. 3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin. Brain Res 1995; 704: 153-66.
76. Aït Amara D, Segu L, Naïli S, Buhot M-C. Serotonin 1B receptor regulation after dorsal subiculum deafferentation. Brain Res Bull 1995; 38: 17-23.
77. Boeijinga PH, Boddeke HWGM. Activation of 5-HT1B receptors suppresses low but not high frequency synaptic transmission in the rat subicular cortex in vitro. Brain Res 1996; 721: 59-65.
78. Consolo S, Arnaboldi S, Ramponi S, Nannini L, Ladinsky H, Baldi G. Endogenous serotonin facilitates in vivo acetylcholine release in rat frontal cortex through 5-HT1B receptors. J Pharmacol Exp Ther 1996; 277: 823-30.
79. Meneses A, Terrón JA, Hong E. Effects of the 5-HT receptor antagonists GR127935 (5-HT1B/1D) and MDL 100907 (5-HT2A) in the consolidation of learning. Behav Brain Res 1997; 89: 217-23.
80. Saudou F, Aït Amara D, Dierich A, LeMeur M, Ramboz S, Segu L, et al. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 1994; 265: 1875-8.
81. Ramboz S, Saudou F, Aït Amara D, Belzung C, Segu L, Misslin R, et al. 5-HT1B receptor knock out - behavioral consequences. Behav Brain Res 1996; 73: 305-12.
82. Malleret G, Hen R, Guillou J-L, Segu L, Buhot M-C. 5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze. J Neurosci 1999; 19: 6157-68.
83. Buhot M-C, Naïli S. Changes in exploratory activity following stimulation of hippocampal 5-HT1A and 5-HT1B receptors in the rat. Hippocampus 1995; 5: 198-208.
84. Boutrel B, Franc B, Hen R, Hamon M, Adrien J. Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice. J Neurosci 1999; 19: 3204-12.
85. Hennevin E, Hars B, Maho C, Bloch V. Processing of learned information in paradoxical sleep: relevance for memory. Behav Brain Res 1995; 69: 125-35.
86. Malleret G, Savova M, Hen R, Segu L, Buhot M-C. 5-HT1B receptor mutation decreases age-related impairment of spatial reference memory performance. Soc Neurosci Abst 1999; 25: 2156.
87. Liu W, Akeja M. Atypical antipsychotics block the excitatory effects of serotonin in septohippocampal neurons in the rat. Neuroscience 1997; 79: 369-82.
88. Hirano H, Day J, Fibiger HC. Serotonergic regulation of acetylcholine release in rat frontal cortex. J Neurochem 1995; 65: 1139-45.
89. Harvey JA. Serotonergic regulation of associative learning. Behav Brain Res 1996; 73: 47-50.
90. Nowakowska E, Chodera A, Kus K, Rybakowski J. Some behavioural effects of risperidone in rats: comparison with haloperidol. Eur Neuropsychopharmacol 1999; 9: 421-6.
91. Applegate CD, Tecott LH. Global increases in seizure susceptibility in mice lacking 5-HT2C receptors: a behavioral analysis. Exp Neurol 1998;154: 522-30.
92. Tecott LH, Logue SF, Wehner JM, Kauer JA. Perturbed dentate gyrus function in serotonin 5-HT2C receptor mutant mice. Proc Natl Acad Sci U S A 1998; 95: 15026-31.
93. Barnes JM, Costall B, Coughlan J, Domeney AM, Gerrard PA, Kelly ME, et al. The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates. Pharmacol Biochem Behav 1990; 35: 955-62.
94. Hong E, Meneses A. Systemic injection of p-chloro-amphetamine eliminates the effect of the 5-HT3 compounds on learning. Pharmacol Biochem Behav 1996; 53: 765-9.
95. Roychoudhury M, Kulkarni SK. Effects of ondansetron on short-term memory retrieval in mice. Meth Find Exp Clin Pharmacol 1997; 19: 43-6.
96. Carli M, Luschi R, Samanin R. Dose-related impairment of spatial learning by intrahippocampal scopolamine: antagonism by ondansetron, a 5-HT3 receptor antagonist. Behav Brain Res 1997; 82: 185-94.
97. Ohno M, Watanabe S. Differential effects of 5-HT3 receptor antagonism on working memory failure due to deficiency of hippocampal cholinergic and glutamatergic transmission in rats. Brain Res 1997; 762: 211-5.
98. Pitsikas N, Borsini F. Different effects of tropisetron and ondansetron in learning and memory paradigms. Pharmacol Biochem Behav 1997; 56: 571-6.
99. Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, et al. The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 1999; 397: 359-63.
100. Arnsten AFT, Lin CH, Van Dyck CH, Stanhope KJ. The effects of 5-HT3 receptor antagonists on cognitive performance in aged monkeys. Neurobiol Aging 1997; 18: 21-8.
101. Terry AVJr, Buccafusco JJ, Prendergast MA, Jackson WJ, Fontana DL, Wong EHF, et al. The 5-HT3 receptor antagonist, RS-56812, enhances delayed matching performance in monkeys. Neuroreport 1996; 8: 49-54.
102. Fontana DJ, Daniels SE, Henderson C, Eglen RM, Wong EHF. Ondansetron improves cognitive performance in the Morris water maze spatial navigation task. Psychopharmacology 1995; 120: 409-17.
103. Hodges H, Sowinski P, Turner JJ, Fletcher A. Comparison of the effects of the 5-HT3 receptor antagonists, WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system. Psychopharmacology 1996; 125: 146-61.
104. Brooks A, Little JT, Martin A, Minichiello MD, Dubbert B, Mack C, et al. The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls. Biol Psychiatry 1998; 43: 408-16.
105. Yoshioka M, Marsumoto M, Togashi H, Saito H. Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex. Pharmacol Biochem Behav 1995; 51: 515-9.
106. Guy NTM, Malmberg AB, Basbaum AL, Julius D. Pain behaviour in 5-HT3 receptor mutant mice. Soc Neurosci Abstr 1997, 23: 290.
107. Staubli U, Xu FB. Effects of 5-HT-sub-3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat. J Neurosci 1995; 15: 2445-52.
108. Morales M, Bloom FE. The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon. J Neurosci 1997; 17: 3157-67.
109. Reznic J, Staubli U. Effects of 5-HT3 receptor antagonism on hippocampal cellular activity in the freely moving rat. J Neurophysiol 1997; 77: 517-21.
110. Ramirez MJ, Cenarruzabeitia E, Lasheras B, Del Rio J. Involvement of GABA systems in acetylcholine release induced by 5-HT3 receptor blockade in slices from rat entorhinal cortex. Brain Res 1996; 712: 274-80.
111. Passant MB, Blandina P. Cognitive implications for H3 and 5-HT3 receptor modulation of cortical cholinergic function: a parallel story. Meth Find Exp Clin Pharmacol 1998; 20: 725-33.
112. Eglen RM, Wong EHF, Dumuis A, Bockaert J. Central 5-HT4 receptors. Trends Pharmacol Sci 1995; 16: 391-8.
113. Van Ge J, Barnes NM. 5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo. Br J Pharmacol 1996; 117: 1475-80.
114. Wong EHF, Reynolds GP, Bonhaus DW, Hsu S, Eglen RM. Characterization of [3H] GR 113808 binding to 5-HT4 receptors in brain tissues from patients with neurodegenerative disorders. Behav Brain Res 1996; 73: 249-52.
115. Fontana DJ, Daniels SE, Wong EHF, Clark RD, Eglen RM. The effects of novel, selective 5-hydroxytryptamine (5HT)4 receptor ligands in rat spatial navigation. Neuropharmacology 1997; 36: 689-96.
116. Terry AV, Buccafusco JJ, Jackson WJ, Prendergast MA, Fontana DJ, Wong EHF, et al. Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017. Psychopharmacology 1998; 135: 407-15.
117. Letty S, Child R, Dumuis A, Pantaloni A, Bockaert J, Rondouin G. 5-HT4 receptors improve social olfactory memory in the rat. Neuropharmacology 1997; 36: 681-7.
118. Marchetti-Gauthier E, Roman FS, Dumuis A, Bockaert J, Soumireu-Mourat B. BIMU1 increases associative memory in rats by activating 5-HT4 receptors. Neuropharmacology 1997; 36: 697-706.
119. Meneses A, Hong E. Effects of 5-HT4 receptor agonists and antagonists in learning. Pharmacol Biochem Behav 1997; 56: 347-51.
120. Uphouse L. Multiple serotonin receptors: too many, not enough, or just the right number? Neurosci Biobehav Rev 1997; 21: 679-98.
121. Stoppe G, Brandt CA, Staedt JH. Behavioural problems associated with dementia: the role of newer antipsychotics. Drugs Aging 1999; 14: 41-54.
122. Mayford M, Mansuy IM, Muller RU, Kandel ER. Memory and behavior: a second generation of genetically modified mice. Curr Biol 1997; 7: R580-9.
123. Stark KL, Ghavami A, Segu L, Mayford M, Kandel K, Hen R. Inducible knockout and tissue-specific rescue of the 5-HT1B receptor. Soc Neurosci Abstr 1997; 23: 290.
124. Mansuy IM, Winder DG, Moallem TM, Osman M, Mayford M, Hawkins RD, et al. Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron 1998; 21: 257-65.
125. Fletcher L. Memories are made of this: the genetic basis of memory. Mol Med Today 1997; 3: 429-34.